Answers are grounded in this paper and cite their sources.
The main objective of Phase III clinical trials of medicinal products in humans is to confirm the therapeutic efficacy observed in Phase II on a large number of patients in a given disease. This is the phase from chemical to drug status.
No takes yet. Share an insight, caveat, or question.
Michel Bourin (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: